May 14, 2020 ENZYCHEM LIFESCIENCES INITIATES PHASE 2 STUDY FOR EC-18 IN PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) DUE TO NOVEL CORONAVIRUS PNEUMONIA Explore further
May 1, 2020 ENZYCHEM LIFESCIENCES ANNOUNCES PUBLICATION OF PRECLINICAL STUDY OF EC-18 IN GOUTY ARTHRITIS IN FRONTIERS IN IMMUNOLOGY Explore further
March 17, 2020 ENZYCHEM LIFESCIENCES ANNOUNCES PLANS TO ADVANCE CLINICAL TRIAL IN SOUTH KOREA FOR EC-18 AS A POTENTIAL THERAPEUTIC FOR COVID-19 INFECTION Explore further
January 28, 2020 ENZYCHEM LIFESCIENCES APPOINTS DR. MICHAEL CHARLTON TO ITS SCIENTIFIC ADVISORY BOARD Explore further
January 6, 2020 ENZYCHEM LIFESCIENCES TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO Explore further
December 6, 2019 ENZYCHEM LIFESCIENCES ANNOUNCES COLLABORATIVE MATERIAL TRANSFER AGREEMENT (MTA) WITH THE ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE (AFRRI) FOR THE DEVELOPMENT OF A RADIATION MEDICAL COUNTERMEASURE. Explore further
